Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice
Fig 1
Comparison of pre-challenge reciprocal 90% end-point titers for mice vaccinated with BbHtrAS226A or BbHtrAWT in Imject Alum or TiterMax adjuvants.
0 corresponds to baseline established from adjuvant-only, pre-challenge serum at day 70. Bars represent median values.